Scarica l'app Stockscreener
33.15
0.15%
0.05
Dopo l'orario di chiusura:
33.08
-0.07
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Dimensional Fund Advisors LP Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Royalty pharma projects 6-12% growth in 2025 portfolio receipts with $2B share buyback plan - MSN
10,893 Shares in Royalty Pharma plc (NASDAQ:RPRX) Acquired by Corton Capital Inc. - MarketBeat
Royalty Pharma Q1 2025 slides: double-digit growth drives raised guidance - Investing.com Nigeria
Royalty Pharma Reports Strong Q1 2025 Growth - TipRanks
Royalty Pharma Q1 2025 Earnings Call Transcript - MarketBeat
Royalty Pharma’s Earnings Call: Growth and Optimism - TipRanks
Schonfeld Strategic Advisors LLC Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AlTi Global Inc. Buys Shares of 387,567 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Q1 2025 slides: double-digit growth drives raised guidance By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Royalty Pharma Q1 2025 misses EPS estimates - Investing.com
Royalty Pharma plc SEC 10-Q Report - TradingView
Royalty Pharma earnings missed by $0.66, revenue fell short of estimates - Investing.com UK
Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates - Yahoo Finance
Royalty Pharma (RPRX) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Royalty Pharma Reports First Quarter 2025 Results - TradingView
Cutter Capital Management LP Acquires 100,000 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Reports 17% Growth in Portfolio Receipts to $839 Million and Raises 2025 Financial Guidance - Nasdaq
Royalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025 - The Globe and Mail
Caisse DE Depot ET Placement DU Quebec Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AQR Capital Management LLC Boosts Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MML Investors Services LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Northern Trust Corp Purchases 376,619 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
ArrowMark Colorado Holdings LLC Increases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Projected to Post Earnings on Thursday - MarketBeat
PDT Partners LLC Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Hsbc Holdings PLC Sells 30,304 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - Nasdaq
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Regal Partners Ltd - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Tudor Investment Corp ET AL - MarketBeat
First Trust Advisors LP Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wells Fargo & Company MN Buys 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook By Investing.com - Investing.com Nigeria
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook - Investing.com Australia
Walleye Capital LLC Buys Shares of 25,124 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Uniplan Investment Counsel Inc. Buys New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Dark Forest Capital Management LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by GMT Capital Corp - MarketBeat
Barclays PLC Acquires 54,421 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Declares $0.22 Quarterly Dividend - MarketBeat
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):